Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics.
Influenza A viruses are the cause of annual epidemics of human disease with occasional outbreaks of pandemic proportions. The zoonotic nature of the disease and the vast viral reservoirs in the aquatic birds of the world mean that influenza will not easily be eradicated and that vaccines will continue to be needed. Recent technological advances in reverse genetics methods and limitations of the conventional production of vaccines by using eggs have led to a push to develop cell-based strategies to produce influenza vaccine. Although cell-based systems are being developed, barriers remain that need to be overcome if the potential of these systems is to be fully realized. These barriers include, but are not limited to, potentially poor reproducibility of viral rescue with reverse genetics systems and poor growth kinetics and yields. In this study we present a modified A/Puerto Rico/8/34 (PR8) influenza virus master strain that has improved viral rescue and growth properties in the African green monkey kidney cell line, Vero. The improved properties were mediated by the substitution of the PR8 NS gene for that of a Vero-adapted reassortant virus. The Vero growth kinetics of viruses with H1N1, H3N2, H6N1, and H9N2 hemagglutinin and neuraminidase combinations rescued on the new master strain were significantly enhanced in comparison to those of viruses with the same combinations rescued on the standard PR8 master strain. These improvements pave the way for the reproducible generation of high-yielding human and animal influenza vaccines by reverse genetics methods. Such a means of production has particular relevance to epidemic and pandemic use.
Ozaki
Hiroichi
H
Departments of Infectious Disease, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Govorkova
Elena A
EA
Li
Chenghong
C
Xiong
Xiaoping
X
Webster
Robert G
RG
Webby
Richard J
RJ
D000818:Animals; D002522:Chlorocebus aethiops; D006801:Humans; D009980:Influenza A virus / Q000235:genetics / Q000254:growth & development*; D007252:Influenza Vaccines; D016865:Reassortant Viruses / Q000235:genetics / Q000254:growth & development*; D014709:Vero Cells / Q000821:virology*; D017361:Viral Nonstructural Proteins / Q000235:genetics; D014776:Virus Cultivation; D014779:Virus Replication
D007252:Influenza Vaccines; D017361:Viral Nonstructural Proteins